Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,812 | -91,148 | -61,582 | -26,531 | -28,827 |
| Depreciation Amortization | 1,301 | 4,383 | 3,107 | 2,061 | 1,044 |
| Income taxes - deferred | 0 | -7,800 | 0 | 0 | N/A |
| Accounts receivable | 1,374 | 3,708 | 3,790 | 3,462 | 2,979 |
| Accounts payable and accrued liabilities | 358 | -2,851 | -3,346 | -2,814 | 140 |
| Other Working Capital | -6,319 | -2,488 | -7,693 | -5,986 | 3,155 |
| Other Operating Activity | 2,256 | 10,120 | 5,174 | 3,918 | -1,854 |
| Operating Cash Flow | $-22,842 | $-86,076 | $-60,550 | $-25,890 | $-23,363 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -741 | -23,887 | -19,479 | -10,536 | -1,365 |
| Purchase Of Investment | -77,375 | -359,500 | -316,098 | -244,250 | -138,564 |
| Sale Of Investment | 115,098 | 351,322 | 306,264 | 233,108 | 130,509 |
| Other Investing Activity | 0 | 0 | -468 | 0 | 0 |
| Investing Cash Flow | $36,982 | $-32,065 | $-29,781 | $-21,678 | $-9,420 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,996 | 38,641 | 32,937 | 865 | 299 |
| Other Financing Activity | 0 | 4,444 | 4,921 | 2,185 | 2,161 |
| Financing Cash Flow | $17,996 | $43,085 | $37,858 | $3,050 | $2,460 |
| Beginning Cash Position | 75,400 | 150,456 | 150,456 | 150,456 | 150,456 |
| End Cash Position | 107,536 | 75,400 | 97,983 | 105,938 | 120,133 |
| Net Cash Flow | $32,136 | $-75,056 | $-52,473 | $-44,518 | $-30,323 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,842 | -86,076 | -60,550 | -25,890 | -23,363 |
| Capital Expenditure | -741 | -23,887 | -19,479 | -10,536 | -1,365 |
| Free Cash Flow | -23,583 | -109,963 | -80,029 | -36,426 | -24,728 |